Breastfeeding linked with decreased breast cancer recurrence risk
the ONA take:
According to a new Kaiser Permanente study published in the Journal of the National Cancer Institute, women diagnosed with breast cancer who previously breastfed their babies had a 30% overall decreased risk of disease recurrence.
For the study, researchers analyzed data from 1,636 women with breast cancer who completed a questionnaire that included breastfeeding history.
Researchers observed significant benefits between women who had a history of breastfeeding and outcomes of those diagnosed with the luminal A subtype of breast cancer, such as estrogen-receptor positive tumors. Results also showed women who breastfed were 28% less likely to die from the disease.
"Women who breastfeed are more likely to get the luminal A subtype of breast cancer, which is less aggressive, and breastfeeding may set up a molecular environment that makes the tumor more responsive to anti-estrogen therapy," lead author Marilyn L. Kwan, PhD said as a possible explanation of the observed association.
Women diagnosed with breast cancer who previously breastfed their babies had a 30% overall decreased risk of disease recurrence.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|